Sjögren syndrome induced by anti PDL-1 treatment for TNBC: case report and review of literature
BackgroundRheumatological toxicity associated with immunotherapy, particularly Sjögren’s syndrome (SjS), has been observed with variable incidence in patients treated with immune checkpoint inhibitors (ICIs). Although SjS is a well-known autoimmune dis…